Our Workshop Sessions
1167: "Next-generation human risk assessment toward regulatory acceptance using read-across case studies”
Tuesday, March 29, 2022, 3:50-4:10 p.m., Ballroom 6E
Presenting author: Sylvia Escher
2017: "Influence of extremely low-frequency magnetic fields on the development of childhood leukemia: An experimental study in a susceptible mouse model”
Monday, March 28, 2022, 4:00-4:15 p.m., CC Room 8
Presenting author: Dmitrij Sachno
Our Exhibitor-Hosted Sessions
Fraunhofer vs. Corona: Drug Repurposing Using the Example of Inhalation Therapy Against Covid-19
Monday, March 28, 2022, 9:00-10:00 a.m., CC Room 22
New drugs against Covid-19 are urgently needed. Repurposing of existing drugs enables faster development and minimizes risks. Inhalable drugs offer the benefits of non-invasive administration and less systemic side effects. Within the DRECOR project, we selected and identified drug repurposing candidates using in-vitro/in-vivo inhalation studies and PK/Tox assessments.
PBPK Modeling: The Road to Systemic Toxicity from External to Internal Exposure
Tuesday, March 29, 2022, 9:00-10:00 a.m., CC Room 22
Physiologically-based pharmacokinetic (PBPK) models intrinsically link external and internal exposure, dose response, and target organ toxicity. Integration of innovative in vitro test systems and knowledge on in vivo physiological parameters are crucial for an integrated approach to testing and assessment (IATA). Our PBPK model specifically addresses the complex dosimetry for inhalation toxicity.
Indoor Air Quality and Human Exposure
Wednesday, March 30, 2022, 9:00-10:00 a.m., CC Room 22
Nowadays, people spend most of their lives indoors – at work, home, schools, or traveling. Indoor air pollution has become an increasingly important issue, with one focus on ventilation and filter systems. Fraunhofer ITEM combines expertise in inhalation toxicology with chemical analyses and human exposure for selected scenarios.